[DPHARMA] QoQ Cumulative Quarter Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 89.98%
YoY- -8.6%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 45,599 176,961 125,937 81,118 40,495 162,405 116,671 -46.57%
PBT 12,198 46,509 32,589 21,302 11,175 40,175 31,017 -46.35%
Tax -3,229 0 -8,014 -5,410 -2,810 -7,900 -6,842 -39.41%
NP 8,969 46,509 24,575 15,892 8,365 32,275 24,175 -48.39%
-
NP to SH 8,969 35,271 24,575 15,892 8,365 32,275 24,175 -48.39%
-
Tax Rate 26.47% 0.00% 24.59% 25.40% 25.15% 19.66% 22.06% -
Total Cost 36,630 130,452 101,362 65,226 32,130 130,130 92,496 -46.10%
-
Net Worth 205,045 192,942 187,436 179,045 190,050 181,850 179,125 9.43%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div - 25,679 5,553 5,551 - 24,293 - -
Div Payout % - 72.81% 22.60% 34.93% - 75.27% - -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 205,045 192,942 187,436 179,045 190,050 181,850 179,125 9.43%
NOSH 139,486 138,807 138,841 138,794 138,723 138,817 138,856 0.30%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 19.67% 26.28% 19.51% 19.59% 20.66% 19.87% 20.72% -
ROE 4.37% 18.28% 13.11% 8.88% 4.40% 17.75% 13.50% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 32.69 127.49 90.71 58.44 29.19 116.99 84.02 -46.73%
EPS 6.43 25.41 17.70 11.45 6.03 23.25 17.41 -48.55%
DPS 0.00 18.50 4.00 4.00 0.00 17.50 0.00 -
NAPS 1.47 1.39 1.35 1.29 1.37 1.31 1.29 9.10%
Adjusted Per Share Value based on latest NOSH - 138,872
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 4.74 18.40 13.09 8.43 4.21 16.88 12.13 -46.58%
EPS 0.93 3.67 2.55 1.65 0.87 3.36 2.51 -48.44%
DPS 0.00 2.67 0.58 0.58 0.00 2.53 0.00 -
NAPS 0.2132 0.2006 0.1949 0.1861 0.1976 0.189 0.1862 9.45%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 3.88 2.50 3.17 2.97 3.03 2.58 2.55 -
P/RPS 11.87 1.96 3.49 5.08 10.38 2.21 3.03 148.71%
P/EPS 60.34 9.84 17.91 25.94 50.25 11.10 14.65 157.16%
EY 1.66 10.16 5.58 3.86 1.99 9.01 6.83 -61.08%
DY 0.00 7.40 1.26 1.35 0.00 6.78 0.00 -
P/NAPS 2.64 1.80 2.35 2.30 2.21 1.97 1.98 21.16%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 24/02/15 21/11/14 26/08/14 20/05/14 26/02/14 19/11/13 -
Price 3.90 2.92 3.01 3.37 3.09 2.60 2.56 -
P/RPS 11.93 2.29 3.32 5.77 10.59 2.22 3.05 148.45%
P/EPS 60.65 11.49 17.01 29.43 51.24 11.18 14.70 157.46%
EY 1.65 8.70 5.88 3.40 1.95 8.94 6.80 -61.13%
DY 0.00 6.34 1.33 1.19 0.00 6.73 0.00 -
P/NAPS 2.65 2.10 2.23 2.61 2.26 1.98 1.98 21.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment